Cara Therapeutics: Scratching An Itch Left Unscratched | Latest News RSS feed

Cara Therapeutics: Scratching An Itch Left Unscratched - Latest News


Cara Therapeutics: Scratching An Itch Left Unscratched

CARA therapeutics wholly owns its proprietary kappa opioid-receptor agonist, KORSUVA/CR845, and is targeting several largely underserved markets. Several catalysts are expected throughout the next yea... read more

Here's Why Cara Therapeutics Rose 12.5% in August

That jumbled mess of scientific words essentially means Cara Therapeutics is developing a drug to treat itching that arises in some patients ... high-risk pharma stock that's best left to investors wi... read more

Cara Therapeutics Is Scratching the Itch for Promising Biotechs

Micro-cap biotech Cara Therapeutics (NASDAQ: CARA) reported another in a string of positive trial results for its pain and itching drug, CR845. As the risk of failure for its only drug in human trials ... read more

Looking for another news?


Small-Cap Snapshot: Cara Therapeutics lands licensing deal, Revlon appoints its first female CEO

Biotech Cara Therapeutics Inc (NASDAQ:CARA) was a top gainer following a licensing deal for its drug Korsuva, an injectable used to treat itching as a result of kidney dialysis. The Connecticut-based ... read more


Cara Therapeutics shares pop on a lucrative licensing deal for its drug Korsuva

Shares of Cara Therapeutics (NASDAQ:CARA ... The agreement offers Vifor Fresenius the chance to sell Korsuva, Cara’s injectable drug for itching which results from kidney dialysis, most everywhere, ap... read more

Cara Therapeutics' (CARA) CEO Derek Chalmers on Q1 2015 Results - Earnings Call Transcript

Cara Therapeutics Inc. (NASDAQ ... of I.V. CR845 compared to placebo and reducing the intensity of itch in these patients over a two week dosing period. Endpoints include change in worse itching score... read more

Here's Why Cara Therapeutics Jumped 26.3% in May

Shares of Cara Therapeutics (NASDAQ: CARA ... Medical Care Renal Pharma to license most of the ex-U.S. rights to Korsuva, Cara's treatment for itching associated with chronic kidney disease in dialysi... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us